GSK CEO Emma Walmsley total remuneration rises 51 percent to USD 16 million in 2023 Ruchika Sharma4 March 2024 10:00 AM ISTLondon: GSK CEO Emma Walmsley's total remuneration rose 51 per cent to 12.7 million pounds ($16 million) in 2023, thanks to a big jump in...
Heartburn drug: GSK settles another lawsuit on Zantac in California Ruchika Sharma3 March 2024 2:00 PM ISTThe USFDA in 2020 pulled all brands named Zantac and generic versions of the drug off the market, triggering a wave of lawsuits.
Gepotidacin potential novel oral treatment option for uncomplicated gonorrhoea: EAGLE-1 phase III trial shows Medha Baranwal2 March 2024 2:15 AM ISTUK: Gepotidacin, a first-in-class triazaacenaphthylene antibiotic, demonstrated non-inferiority to the current standard-of-care gonorrhoea treatment...
GSK posts positive headline results from phase III trial for Gepotidacin in uncomplicated urogenital gonorrhoea Ruchika Sharma27 Feb 2024 2:30 PM ISTGSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, a potential first-in-class oral antibiotic...
Indian Pharmaceutical Market soars with 9.5% growth in January 2024: Pharmarack Report Farhat Nasim20 Feb 2024 5:56 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) exhibited a robust growth of 9.5% in terms of value and 2.07% in units, reaching a total value of...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
GSK gets USFDA Fast Track designation for Bepirovirsen in chronic hepatitis B Ruchika Sharma12 Feb 2024 3:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an...
USFDA accepts under priority review GSK application to extend indication of adjuvanted RSV vaccine Ruchika Sharma8 Feb 2024 4:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted under priority review an application to extend the...
GSK application for Shingrix for shingles prevention in at-risk adults aged 18 and over accepted for review in China Ruchika Sharma8 Feb 2024 1:30 PM ISTLondon: GSK plc has announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted...
GSK vaccine Arexvy accepted for regulatory review by EMA for adults aged 50-59 at increased risk for RSV Ruchika Sharma4 Feb 2024 10:00 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to expand the use of its...
GSK settles another Zantac lawsuit in California Ruchika Sharma1 Feb 2024 4:15 PM ISTCalifornia: GSK said on Thursday it had agreed to settle another lawsuit in California that alleged its discontinued heartburn drug Zantac...
GSK Omjjara gets European Commission marketing authorisation Ruchika Sharma29 Jan 2024 4:45 PM ISTLondon: GSK plc has announced the European Commission has granted marketing authorisation for Omjjara (momelotinib), a once-a-day, oral JAK1/JAK2...
